Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal −/− mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal
−/−
mice
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 15, Pages 1938-1948
Publisher
Springer Nature
Online
2014-06-02
DOI
10.1038/onc.2014.143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloid-Specific Expression of Api6/AIM/Sp Induces Systemic Inflammation and Adenocarcinoma in the Lung
- (2014) P. Qu et al. JOURNAL OF IMMUNOLOGY
- Critical Role of the mTOR Pathway in Development and Function of Myeloid-Derived Suppressor Cells in lal−/− Mice
- (2013) Xinchun Ding et al. AMERICAN JOURNAL OF PATHOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- Gene Profile of Myeloid-Derived Suppressive Cells from the Bone Marrow of Lysosomal Acid Lipase Knock-Out Mice
- (2012) Cong Yan et al. PLoS One
- Inhibition of PPAR in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis
- (2011) L. Wu et al. BLOOD
- Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a key role in modulating myelopoiesis, immune suppression, and lung tumorigenesis
- (2011) P. Qu et al. BLOOD
- Myeloid-Specific Expression of Human Lysosomal Acid Lipase Corrects Malformation and Malfunction of Myeloid-Derived Suppressor Cells in lal-/- Mice
- (2011) P. Qu et al. JOURNAL OF IMMUNOLOGY
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Critical Roles of Lysosomal Acid Lipase in Myelopoiesis
- (2010) Peng Qu et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1
- (2010) Ting Zhao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- IL4Rα + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
- (2009) Susanna Mandruzzato et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
- (2009) A. Bonauer et al. SCIENCE
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease
- (2008) Peng Qu et al. LUNG CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started